Table 2.
RECIST 1.1 | |
---|---|
Target lesion | |
Measurable lesions | Longest diameter of tumors or metastasis ≥1.0 cm |
Short axis of lymph node metastasis ≥1.0 cm | |
Nonmeasurable | Longest diameter <10 mm or pathological lymph nodes with ≥10 to <15 mm short axis) |
Leptomeningeal disease, ascites, pleural or pericardial effusion, inflammatory breast disease, lymphangitic involvement of skin or lung, bone metastasis without soft tissue component | |
Measurements | Up to 5 lesions, with a maximum of 2 lesions per organ |
Abbreviation: RECIST, Response Evaluation Criteria in Solid Tumors.